Skip to main content

Table 3 Frequency of CYP3A4 and CYP3A5 polymorphisms in 20 HIV-infected patients

From: Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs

Genotype/20 pts

Gene

Polymorphism

wt ( n. pts)

m ( n. pts)

CYP3A4

   
 

CYP3A4*1B; 816 A > G 5′-flanking region

17/20

3

 

CYP3A4*2; 15831 T < C exon 7

20

 
 

CYP3A4*4; 13989 A > G exon 5

20

 
 

CYP3A4*5; 15820 C > G exon 7

20

 
 

CYP3A4*6; 17775 insA exon 9

20

 
 

CYP3A4*8; 14026 G > A exon 5

20

 
 

CYP3A4*11; 21973 C > T exon 11

20

 
 

CYP3A4*12; 22002 C > T exon 11

20

 
 

CYP3A4*13; 22132 C > T exon 11

20

 
 

CYP3A4*16; 15721 C > G exon 7

20

 
 

CYP3A4*17; 15733 T > C exon 7

20

 
 

CYP3A4*18; 20178 T > C exon 10

20

 

CYP3A5

   
 

CYP3A5*3; 12083 G > A intron 3

17/20

3

 

CYP3A5*5; 18049 T > C intron 5

20

 
 

CYP3A5*6; 19787 G > A exon 7

20

 
 

CYP3A5*8; 8801 C > T exon 2

20

 
 

CYP3A5*9; 24483 G > A exon 10

20

 
 

CYP3A5*10; 34850 T > C exon 12

20

 
  1. Wt: wild-type, m: mutated.